Kennedy Jr. delivered a keynote address at a Children’s Health Defense conference in Washington, marking his first public embrace of the anti-vaccine nonprofit since taking charge of HHS. The appearance … Read More
AstraZeneca’s experimental injectable biologic drug, tozorakimab, successfully reduced dangerous flare-ups in late-stage Phase 3 clinical trials for chronic obstructive pulmonary disease (COPD). Presented at the European Respiratory Society annual conference … Read More
The Maryland Department of Health plans to incorporate food- and nutrition-related services as approved In-Lieu-of-Services within HealthChoice, the state’s Medicaid program, starting in 2028. This strategic regulatory shift aims to … Read More
Sanofi (EURONEXT: SAN) secures FDA approval for Tzield (teplizumab) in pediatric stage 3 type 1 diabetes, expanding its endocrinology franchise by 15% in revenue potential and positioning it as the … Read More
A study published this week in Safety+Health Magazine suggests that accepting “sufficient” pain levels may be “ideal” for workers with chronic conditions, according to a multicenter trial involving 1,200 participants … Read More
Eli Lilly’s experimental obesity therapy, retatrutide, has demonstrated significant weight reduction in late-stage clinical trials, including patients with Type 2 diabetes. While efficacy is high, recent data presented at the … Read More
Triple Hormone Receptor Obesity Drug Faces Regulatory Crossroads Amid Mixed Trial Outcomes Published this week at the American Diabetes Association conference, a monthly obesity drug targeting triple hormone receptors has … Read More
Heart health nutritionists recommend three subtle dietary adjustments—increasing soluble fiber, swapping saturated fats for polyunsaturated fats, and reducing refined sugars—to lower the risk of cardiovascular disease (CVD). These evidence-based tweaks … Read More
New guidelines released by leading medical organizations advocate for initiating cholesterol management, including statin therapy, as early as age 30. This marks a significant shift from the previous recommendation of … Read More
New research suggests a concerning link between a father’s nicotine exposure and an increased risk of diabetes in his children. A recent study published in the Journal of the Endocrine … Read More
